```html

Xanthopsia (Psychological)

What is Xanthopsia (psychological)?

Xanthopsia (from the Greek xanthos = yellow and opsis = vision) is a type of color vision disturbance in which objects appear tinged with yellow. When the condition originates from a mental‑health or neurological source rather than an ocular disease, it is referred to as psychological xanthopsia. In this form, the brain’s processing of visual signals is altered by factors such as medication side‑effects, substance use, migraine aura, or psychiatric disorders.

Unlike the physiological form caused by cataracts or retinal disease, psychological xanthopsia usually presents without structural eye damage. The perception of a yellow hue can be constant, intermittent, or triggered by specific situations (e.g., bright light, stress). Because color perception is a complex interaction between the retina, optic pathways, and visual cortex, disturbances can be an early clue to systemic or neuro‑psychiatric illness.

Common Causes

Below are the most frequently reported conditions and situations that can produce psychological xanthopsia. Each cause may act alone or in combination with others.

• Medication side‑effects – especially digitalis (digoxin), quinine, certain antibiotics (e.g., chlorpromazine), antipsychotics, and some antidepressants.
• Substance use – chronic exposure to solvents, benzodiazepines, cannabis, or hallucinogenic drugs (e.g., LSD, psilocybin).
• Migraine with aura – visual aura can include color shifts toward yellow or gold.
• Epilepsy – focal seizures involving the occipital lobe may cause transient color distortions.
• Psychiatric disorders – severe anxiety, depression, or psychotic episodes sometimes alter visual perception.
• Traumatic brain injury (TBI) – diffuse axonal injury or contusions in the visual cortex.
• Stroke – especially posterior circulation strokes affecting the occipital lobe.
• Neurodegenerative disease – early Parkinson’s disease or Alzheimer’s disease can produce subtle color vision changes.
• Metabolic disturbances – hypoglycemia, hepatic encephalopathy, or severe electrolyte imbalance.
• Chronic fatigue syndrome / fibromyalgia – reported in a minority of patients with central sensitization.

Associated Symptoms

Psychological xanthopsia rarely occurs in isolation. Patients often report one or more of the following accompanying signs:

• Headache or migraine aura
• Light sensitivity (photophobia)
• Blurred or double vision (diplopia)
• Visual halos around lights
• Transient vision loss or “blackouts”
• Confusion, disorientation, or memory lapses
• Auditory or tactile hallucinations (usually with psychosis)
• Fatigue, sleep disturbances, or mood swings
• Balance problems or gait instability (especially with stroke or TBI)

When to See a Doctor

Because color‑vision changes can signal serious underlying disease, patients should seek professional evaluation promptly when any of the following occur:

• Sudden onset of yellow‑tinged vision, especially if it lasts longer than a few minutes.
• Vision changes after starting a new medication or changing the dose.
• Accompanying neurological symptoms such as weakness, numbness, slurred speech, or loss of coordination.
• Recurrent episodes that interfere with daily tasks like driving, reading, or operating machinery.
• Severe headache, vomiting, or altered mental status.
• History of head trauma, stroke, or seizure disorder with new visual changes.
• Any visual disturbance that feels “different” from your usual vision, even if it seems mild.

Diagnosis

Diagnosing psychological xanthopsia involves a systematic assessment to rule out ocular disease and identify the neural or systemic trigger.

1. Detailed Medical History

• Onset, duration, and pattern of the yellow tint.
• Medication list (prescription, OTC, supplements) and recent changes.
• Substance use, including alcohol, cannabis, and illicit drugs.
• History of migraines, seizures, head injury, stroke, or psychiatric illness.
• Associated symptoms (headache, nausea, confusion, etc.).

2. Visual‑Function Tests

• Color vision testing – Ishihara plates, Farnsworth‑Munsell 100 Hue Test, or anomaloscope to quantify yellow bias.
• Standard eye exam – slit‑lamp, intra‑ocular pressure measurement, and fundus examination to exclude cataracts or retinal disease.
• Visual field testing – helps detect occipital‑lobe lesions.

3. Neurological Evaluation

• Focused neurologic exam (cranial nerves, motor, sensory, coordination).
• Neuro‑imaging when indicated: CT for acute bleed or fracture; MRI with diffusion‑weighted imaging for stroke, demyelination, or tumor.
• Electroencephalogram (EEG) if seizures or aura are suspected.

4. Laboratory Studies

• Complete blood count, metabolic panel, liver function, and thyroid studies.
• Serum drug levels for digoxin, quinine, or antiepileptic drugs when relevant.
• Urine toxicology screen if illicit drug use is a possibility.

5. Psychiatric Assessment

If medication side‑effects or psychiatric illness are suspected, a mental‑health professional may perform standardized screening tools (PHQ‑9, GAD‑7) and medication‑review protocols.

Treatment Options

Treatment focuses on correcting the underlying cause while providing symptomatic relief.

1. Medication Review & Adjustment

• Discontinue or replace offending drugs (e.g., switch digoxin to an alternative heart‑failure agent).
• Gradual tapering of psychotropic medications under supervision to avoid withdrawal‑related visual changes.

2. Management of Specific Conditions

• Migraine – acute treatment with triptans or NSAIDs; preventive therapy with beta‑blockers, CGRP antagonists, or magnesium.
• Seizure disorders – optimize antiepileptic drug levels; consider surgical or neuro‑stimulation options if refractory.
• Stroke or TBI – acute reperfusion therapy (if applicable), rehabilitation, and neuro‑protective strategies.
• Psychiatric illness – psychotherapy, adjustment of antidepressant/antipsychotic regimen, and stress‑reduction techniques.

3. Symptomatic Relief

• Use of tinted glasses (preferably neutral density or blue‑blocking lenses) can reduce the perceived yellow hue for some patients.
• Regular breaks from digital screens (20‑20‑20 rule) to lessen visual fatigue.
• Adequate hydration and balanced electrolytes, especially for patients on diuretics or with metabolic disturbances.

4. Lifestyle & Home Measures

• Maintain a consistent sleep schedule (7–9 hours/night) to reduce migraine and seizure triggers.
• Limit caffeine and alcohol intake, both of which can precipitate migraine aura.
• Engage in stress‑management practices—mindfulness, yoga, or progressive muscle relaxation.
• Stay current with vaccinations and routine health checks to prevent infections that could exacerbate metabolic encephalopathies.

Prevention Tips

While not all causes are preventable, many risk factors can be mitigated:

• Medication safety: Keep an up‑to‑date list of all drugs; ask your pharmacist or physician about visual side‑effects before starting new therapy.
• Substance awareness: Avoid recreational drugs known to affect vision; use alcohol in moderation.
• Head‑injury protection: Wear helmets when cycling, motorcycling, or participating in contact sports.
• Cardiovascular health: Control blood pressure, cholesterol, and glucose to reduce stroke risk.
• Regular eye examinations: At least once every two years for adults, more often if you have chronic systemic disease.
• Manage migraines early: Identify personal triggers (bright light, certain foods) and implement prophylactic measures.

Emergency Warning Signs

If you experience any of the following, seek emergency medical care (call 911 or go to the nearest emergency department) immediately:

• Sudden, severe headache that feels “different” from a usual migraine.
• Rapid loss of vision or sudden increase in the intensity of the yellow tint.
• Weakness or numbness on one side of the body, slurred speech, or facial drooping.
• Severe nausea/vomiting together with visual changes.
• Loss of consciousness, seizures, or a rapid decline in mental status.
• Chest pain or palpitations accompanied by visual disturbances (possible digoxin toxicity).

---

Understanding psychological xanthopsia helps patients and clinicians identify potentially serious systemic or neurological problems early. Prompt evaluation, targeted treatment, and preventive strategies can restore normal color perception and reduce the risk of complications.

```